Filter by
Press releases (195)
RSSEuroHPC JU has signed a contract with a CSC-IT led consortium to develop the EuroHPC Federation Platform. It will integrate supercomputing, AI systems, quantum computing & data resources across Europe, enhancing user access to advanced technologies.
EuroHPC JU has signed agreements with LuxProvide (Luxembourg) & SURF (Netherlands) to host & operate two new quantum computers. The procurement of these systems will start early next year driving Europe's leadership in quantum computing technologies.
The EuroHPC JU is launching a call to build a high-speed, secure network connecting European supercomputers and data centers, creating a hyperconnected and federated HPC and quantum computing ecosystem.
Supported by EuroHPC JU funding, the NET4EXA research and innovation project aims to develop innovative interconnect technologies, which are high-speed systems that enable seamless communication between supercomputers components.
The EuroHPC Joint Undertaking (EuroHPC JU) selected today the sites that will host the first European AI Factories, set to be deployed next year across Europe: in Finland, Germany, Greece, Italy, Luxembourg, Spain and Sweden.
The Innovate consortium, led by CINECA and including seven Italian industrial partners from diverse sectors, has been selected to host and operate the first EuroHPC industrial-grade supercomputer in Bologna, Italy.
The EuroHPC Joint Undertaking launches a call to extend the Master Programme in HPC. The new programme aims to strengthen Europe’s HPC expertise further and develop the next generation of highly skilled workforce.
UNBABEL today announces the release of the EuroLLM-9B model – a large language model (LLM) created especially to support all 24 official EU languages.
The Jülich Supercomputing Centre (JSC) at Forschungszentrum Jülich received a 100-qubit quantum computer from Pasqal in mid-November. The new quantum computer is part of the EuroHPC JU project HPCQS & will be coupled with the JURECA DC supercomputer.
Thanks to EuroHPC JU funding, MICROCARD-2 and dealii-X will transform computational modeling of the human body and facilitate advances in medicine which will help address critical healthcare challenges.